摘要
淀粉样β蛋白42(Aβ42)和40个氨基酸(Aβ40)累积形成的老年斑(SP)和脑血管淀粉样蛋白沉积物被认为是阿尔茨海默氏病(AD)的诊断特征。若干连接于Aβ前体蛋白(APP)上的家族性AD(FAD)的罕见突变,包括早老-1(PS1)、Presenilin-2(PS2)、Adamalysin10,并且如ε4等位基因其它遗传风险因素为散发性AD载脂蛋白E(载脂蛋白Eε4)的促进Aβ的积聚,并诱导与疾病相关的病理的整个频谱。因此Aβ的积累是一个关键的病态事件和AD预防和治疗的首要目标。 APP是由β位APP裂解酶(BACE1)和γ分泌,多亚基PS1/ PS2含积分膜蛋白酶,连续处理,以产生Aβ。虽然Aβ聚集在所有形式的AD,受到影响的FAD增加Aβ产生已知的唯一途径是由APP基因复制或者通过APP碱基置换和γ分泌亚基PS1和PS2,其特异的增加了更长的Aβ42产量或Aβ40和Aβ42产量同时增加。然而,AD患者绝大多数积累Aβ没有发现这些已知的突变。这导致Aβ的降解或清除障碍可能在AD发病的关键作用被提出。几个候选酶,包括胰岛素降解酶(IDE)、脑啡肽酶(NEP)、内皮素转换酶(ECE)、血管紧张素转换酶(ACE)、纤溶酶和基质金属蛋白酶(MMP)已经被确定,有的甚至已在动物模型成功得被评估。一些研究也已经证实了γ分泌酶抑制剂与作用自相矛盾的增加Aβ产生的能力,我们最近已经确定了该机制是通过避开Aβ降解实现的。这一综述概述了Aβ降解的主要细胞通路,对这些通路的全面的表征是未来翻转Aβ的基础 。
关键词: 阿尔茨海默氏病,淀粉样蛋白β的降解,β淀粉样肽,内皮素转化酶,胰岛素降解酶,脑啡肽酶,神经退行性病变。
Current Alzheimer Research
Title:Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease
Volume: 12 Issue: 1
Author(s): Robert J. Baranello, Krishna L. Bharani, Vasudevaraju Padmaraju, Nipun Chopra, Debomoy K. Lahiri, Nigel H. Greig and Miguel A. Papp
Affiliation:
关键词: 阿尔茨海默氏病,淀粉样蛋白β的降解,β淀粉样肽,内皮素转化酶,胰岛素降解酶,脑啡肽酶,神经退行性病变。
摘要: Amyloid-β proteins (Aβ) of 42 (Aβ42) and 40 aa (Aβ40) accumulate as senile plaques (SP) and cerebrovascular amyloid protein deposits that are defining diagnostic features of Alzheimer’s disease (AD). A number of rare mutations linked to familial AD (FAD) on the Aβ precursor protein (APP), Presenilin-1 (PS1), Presenilin- 2 (PS2), Adamalysin10, and other genetic risk factors for sporadic AD such as the ε4 allele of Apolipoprotein E (ApoE-ε4) foster the accumulation of Aβ and also induce the entire spectrum of pathology associated with the disease. Aβ accumulation is therefore a key pathological event and a prime target for the prevention and treatment of AD. APP is sequentially processed by β-site APP cleaving enzyme (BACE1) and γ-secretase, a multisubunit PS1/PS2-containing integral membrane protease, to generate Aβ. Although Aβ accumulates in all forms of AD, the only pathways known to be affected in FAD increase Aβ production by APP gene duplication or via base substitutions on APP and γ-secretase subunits PS1 and PS2 that either specifically increase the yield of the longer Aβ42 or both Aβ40 and Aβ42. However, the vast majority of AD patients accumulate Aβ without these known mutations. This led to proposals that impairment of Aβ degradation or clearance may play a key role in AD pathogenesis. Several candidate enzymes, including Insulin-degrading enzyme (IDE), Neprilysin (NEP), Endothelin-converting enzyme (ECE), Angiotensin converting enzyme (ACE), Plasmin, and Matrix metalloproteinases (MMPs) have been identified and some have even been successfully evaluated in animal models. Several studies also have demonstrated the capacity of γ-secretase inhibitors to paradoxically increase the yield of Aβ and we have recently established that the mechanism is by skirting Aβ degradation. This review outlines major cellular pathways of Aβ degradation to provide a basis for future efforts to fully characterize the panel of pathways responsible for Aβ turnover.
Export Options
About this article
Cite this article as:
J. Baranello Robert, L. Bharani Krishna, Padmaraju Vasudevaraju, Chopra Nipun, K. Lahiri Debomoy, H. Greig Nigel and A. Papp Miguel, Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease, Current Alzheimer Research 2015; 12 (1) . https://dx.doi.org/10.2174/1567205012666141218140953
DOI https://dx.doi.org/10.2174/1567205012666141218140953 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Activation of Human Platelets by 2-Arachidonoylglycerol: Role of PKC in NO/cGMP Pathway Modulation
Current Neurovascular Research Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Anti-Cancer Agents in Medicinal Chemistry PPAR-γ: Therapeutic Prospects in Parkinson's Disease
Current Drug Targets Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design G Protein - Mediated Signaling: Same Receptor, Multiple Effectors
Current Molecular Pharmacology Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
Current Medicinal Chemistry Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain
Current Drug Targets - CNS & Neurological Disorders Nonsteroidal Anti-Inflammatory Drugs in Experimental Parkinsonian Models and Parkinsons Disease
Current Pharmaceutical Design Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Protein Arginine Methyltransferase 1 and its Dynamic Regulation Associated with Cellular Processes and Diseases
Protein & Peptide Letters Liposome-linear polyethyleneimine-DNA Nanocomplexes for Gene Delivery: Preparation, Characterization and In Vitro Transfection Activity
Current Nanoscience Genetically Modified Dendritic Cells for Cancer Immunotherapy
Current Gene Therapy Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins
Anti-Cancer Agents in Medicinal Chemistry DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design Overview of Mechanisms of Cancer Stem Cell Drug Resistance
Current Signal Transduction Therapy Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival
Current Topics in Medicinal Chemistry Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents
Current Neuropharmacology DNA Methyltransferases Inhibitors from Natural Sources
Current Topics in Medicinal Chemistry